Home > Insider Trading > Filing (0001209191-17-059752)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1099219	Metlife Inc	MET	Life Insurance (6311)	134075851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555359	G Christopher Townsend	Level 20, Cityplaza 3 14 Taikoo Wan Road Taikoo Shing K3 00000	President, Asia	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-11-06	25,181	$45.15	25,181	No	4	M	Direct
Common Stock	Disposition	2017-11-06	25,181	$54.34	0	No	4	S	Direct
Common Stock	Acquisiton	2017-11-06	17,425	$45.91	17,425	No	4	M	Direct
Common Stock	Disposition	2017-11-06	17,425	$54.29	0	No	4	S	Direct
Common Stock	Acquisiton	2017-11-06	13,106	$34.33	13,106	No	4	M	Direct
Common Stock	Disposition	2017-11-06	13,106	$54.20	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2017-11-06	25,181	$0.00	25,181	$45.15
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2017-11-06	17,425	$0.00	17,425	$45.91
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2017-11-06	13,106	$0.00	13,106	$34.33

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2024-02-24	No	4	M	Direct
8,713	2025-02-23	No	4	M	Direct
26,216	2026-02-22	No	4	M	Direct

Footnotes

The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4.
The shares were sold in multiple transactions at prices $54.131 to $54.490, inclusive.
The shares were sold in multiple transactions at prices $54.225 to $54.370, inclusive.
The shares were sold in multiple transactions at prices $54.061 to $54.325, inclusive.
The options became exercisable in three equal installments on February 25, 2015, 2016 and 2017.
The options became exercisable in three equal installments on February 24, 2016, 2017 and 2018.
The options became exercisable in three equal installments on February 23, 2017, 2018 and 2019.